Pub. Date : 2011 Jun 13
PMID : 21663700
13 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 2 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 3 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 4 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 5 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 6 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 7 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 8 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 9 | Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects. | Tyrosine | angiotensinogen | Homo sapiens |
| 10 | Moreover, Ang II induced both increased complex phosphatase activity and decreased complex associated PLCbeta1 tyr-phosphorylation, the latter response required regulator of G protein signaling (RGS)-2. | Tyrosine | angiotensinogen | Homo sapiens |
| 11 | Changes in the complex"s PLCbeta1 tyr-phosphorylation and SHP-2"s tyr-phosphorylation as well as SHP-2-PLCbeta1 complex formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCbeta1 tyr-phosphorylation requiring RGS-2. | Tyrosine | angiotensinogen | Homo sapiens |
| 12 | Changes in the complex"s PLCbeta1 tyr-phosphorylation and SHP-2"s tyr-phosphorylation as well as SHP-2-PLCbeta1 complex formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCbeta1 tyr-phosphorylation requiring RGS-2. | Tyrosine | angiotensinogen | Homo sapiens |
| 13 | Changes in the complex"s PLCbeta1 tyr-phosphorylation and SHP-2"s tyr-phosphorylation as well as SHP-2-PLCbeta1 complex formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCbeta1 tyr-phosphorylation requiring RGS-2. | Tyrosine | angiotensinogen | Homo sapiens |